resorcinol has been researched along with geldanamycin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cortes, J; Dawood, S; Scaltriti, M | 1 |
Carnero, A; Ferrer, I; Marrugal, Á; Molina-Pinelo, S; Ojeda, L; Pastor, MD; Paz-Ares, L; Quintanal-Villalonga, Á | 1 |
1 review(s) available for resorcinol and geldanamycin
Article | Year |
---|---|
Molecular pathways: targeting hsp90--who benefits and who does not.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzoquinones; Breast Neoplasms; Cell Proliferation; Clinical Trials as Topic; Female; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Metabolic Networks and Pathways; Molecular Targeted Therapy; Protein Binding; Protein Folding; Receptor, ErbB-2; Resorcinols | 2012 |
1 other study(ies) available for resorcinol and geldanamycin
Article | Year |
---|---|
Impact of Heat Shock Protein 90 Inhibition on the Proteomic Profile of Lung Adenocarcinoma as Measured by Two-Dimensional Electrophoresis Coupled with Mass Spectrometry.
Topics: A549 Cells; Adenocarcinoma of Lung; Benzoquinones; Cell Line, Tumor; Electrophoresis, Gel, Two-Dimensional; Gene Expression Regulation, Neoplastic; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Lung Neoplasms; Mass Spectrometry; Protein Interaction Maps; Proteomics; Resorcinols | 2019 |